Trusted Resources: Education
Scientific literature and patient education texts
Severity of SMA Muscle Impairment Prior to Treatment May Have Implications for Nusinersen Efficacy
source: The American Journal of Managed Care - AJMC
year: 2022
authors: Jaime Rosenberg
summary/abstract:A new study has found that the severity of muscle impairment and scoliosis before treatment may help predict response to nusinersen for certain patients with spinal muscular atrophy (SMA).
The retrospective study of patients with SMA type 2 and 3, published in Brain and Development, found that the severity of fatty infiltration and muscle atrophy at the start of treatment had implications for changes in motor function after treatment with nusinersen. The findings, which the researchers say highlight the importance of early diagnosis and initiation of treatment, come amid efforts to determine efficacy trends among the several treatment options for the condition.
read more
Related Content
-
Sleep Breathing Disorders in Pediatric Patients With Spinal Muscular Atrophy 2Objectives: The study is aimed to analyz...
-
Let’s Start From the BeginningScarlet was born at 40 weeks and 1 day. ...
-
FDA Lifts Partial Clinical Hold on Novartis’ SMA Drug ProgrammeThe US Food and Drug Administration (FDA...
-
Dynamic Balance in Spinal and Bulbar Muscular Atrophy: Relationship Between Strength and Performance of Forward Lung...Introduction: Spinal and bulbar muscular...
-
Lee Rubin, PhDLee Rubin investigates the key molecular...
-
Scholar Rock Provides Corporate Update and Highlights Priorities for 2022Scholar Rock, a clinical-stage biopharma...
-
Kelly HowellKelly Howell is an Associate Director at...